Search
Voyager Therapeutics Inc
VYGRAdd to Watchlist
3.150USD
-0.040-1.25%
Market hours 09/11, 12:52（ET）
193.01MMarket Cap
LossP/E TTM
Voyager Therapeutics Inc (VYGR) Stock Price Target & Forecast
Analyst Rating
Based on 11 analysts giving stock ratings to Voyager Therapeutics Inc in the past month.
Strong Buy
6 Strong Buy
5 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
14.889USD+324.18%
VYGR Analyst Recommendation Trends
In the current month, VYGR has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. VYGR average Analyst price target in the last month is 14.889.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
6
6
6
6
6
6
6
6
5
5
5
5
6
6
6
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11
11
11
11
12
12
12
12
VYGR Analyst Rating for Peer Comparison
Updated: Sep 10, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
IQVIA Holdings Inc
IQV
7
12
6
0
0
25
CRISPR Therapeutics AG
CRSP
4
9
11
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
8
13
2
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Biontech SE
BNTX
4
13
5
0
0
22
Ascendis Pharma A/S
ASND
10
10
0
0
0
20
Financial Forecasting
Based on analysts' estimates, VYGR EPS is projected to reach -0.419 in FY2026Q3, following reported EPS of -0.404 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.51
-0.55
-0.48
-0.42
-0.40
Actual
-0.47
-0.47
-0.40
--
--
Surprise
+8.85%
+14.81%
+16.52%
--
--
FAQs
What is Voyager Therapeutics Inc's expected revenue for the next quarter?
Voyager Therapeutics Inc's expected revenue is 6.35M.
What is Voyager Therapeutics Inc's price target?
Analysts forecast that Voyager Therapeutics Inc's price target is USD 14.89, with the highest forecast at USD 25.00 and the lowest forecast at USD 8.00.
How have Voyager Therapeutics IncVYGR's recent earnings per share performed?
The market expectation was USD -0.40, while Voyager Therapeutics IncVYGR's earnings per share (EPS) for the previous quarter was USD -0.47. EPS for the next quarter is expected at USD -0.42.
What is the analyst rating for Voyager Therapeutics Inc?
Based on the ratings of Voyager Therapeutics Inc's stock from 11 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.